Completed PHASE1 INTERVENTIONAL 3-arm NCT03438604

A Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil Transdermal Delivery System (TDS)

A Phase 1, 2-Way Crossover Study to Evaluate the Effect of Heat Application on the Delivery Profile of Corplex™ Donepezil 5 mg Transdermal Delivery System (TDS) in Healthy Volunteers

Sponsor: Corium, Inc.

Conditions Alzheimer's Disease

Interventions Donepezil TDS

Updated 10 times since 2018 Last updated: Sep 13, 2018 Started: Feb 13, 2018 Primary completion: Jun 19, 2018 Completion: Jun 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Alzheimer's Disease, this trial is completed. The trial is conducted by Corium, Inc. and has accumulated 10 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Nov 2020 — Jan 2021 [monthly]

Completed PHASE1
Oct 2018 — Nov 2020 [monthly]

Completed PHASE1

Status: Active Not Recruiting → Completed

▶ Show 5 earlier versions

Aug 2018 — Oct 2018 [monthly]

Active Not Recruiting PHASE1

Status: Recruiting → Active Not Recruiting
Jun 2018 — Aug 2018 [monthly]

Recruiting PHASE1
May 2018 — Jun 2018 [monthly]

Recruiting PHASE1
Apr 2018 — May 2018 [monthly]

Recruiting PHASE1
Mar 2018 — Apr 2018 [monthly]

Recruiting PHASE1

First recorded

Feb 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Corium, Inc.

Data source: Corium, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Phoenix, United States